Myriapod® NGS PGX Sign Panel: The easy-to-use, CE-IVD NGS Solution for complete Pharmacogenetics insights

The Myriapod® NGS PGX Sign Panel is a next-generation sequencing (NGS) in vitro diagnostic solution, specifically designed to detect genomic variants in genes involved in the absorption, distribution, metabolism, and excretion (ADME) of pharmaceuticals. This comprehensive panel supports clinicians in tailoring pharmacological treatments to individual genetic profiles, enhancing therapeutic efficacy and minimizing adverse drug reactions (ADRs).

Key features:

  • Ready to use: Dry, ready to use, in pre-aliquoted reagent strip format.
  • Fast and Easy: From sample to sequencing in under 8 hours, with minimal hands-on time

Myriapod NGS Dry: Comlexity Made Easy

  • Flexible: Optimised for Illumina® MiSeq™,Miseq™ i100 Plus, and iSeq100™ platforms.
  • Compliant with regulation (EU) 2017/746 [IVDR].
  • Integrated on- premise bioinformatics solution included: For automatic data analysis and interpretation, designed for maximum ease of use and data safety.

Enter your information below to download the brochure

    I confirm that I have read the information on the personal data management.

    I agree to the processing of my personal data according to the above mentioned information

    *Both options must be selected to proceed with the download

    Category

    Realtime PCR

    Validated tools
    Illumina® Miseq™
    Illumina® iSeql100™
    Related publications
    Request information

      Please insert your email address below, we will contact you soon.

      I confirm that I have read the information on the personal data management.

      I agree to the processing of my personal data
      according to the above mentioned information

      *Both options must be selected